Treatment Strategies for Metastatic Castration-Sensitive Prostate Cancer: From “All-Comers” to “Personalized” Approach

Standard treatment for metastatic castration-sensitive prostate cancer (mCSPC) was androgen-deprivation therapy (ADT) for >7 decades, and this was termed the “all-comers” approach. A remarkable evolution in the treatment of mCSPC has been noted in the previous several years. High-quality clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Kenichi, Shiota, Masaki, Minato, Akinori, Matsumoto, Masahiro, Tomisaki, Ikko, Fujisawa, Masato, Fujimoto, Naohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107048/
https://www.ncbi.nlm.nih.gov/pubmed/33981146
http://dx.doi.org/10.2147/OTT.S306345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107048/
https://www.ncbi.nlm.nih.gov/pubmed/33981146
http://dx.doi.org/10.2147/OTT.S306345

Ejemplares similares